Calcipotriol/betamethasone foam for proactive management of plaque psoriasis: four case reports
Psoriasis is a chronic inflammatory disease affecting about 100 million people worldwide. Around 80% of patients can be treated with topical agents, most commonly corticosteroids and vitamin D analogues. A topical foam formulation of calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) (...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioExcel Publishing Ltd
2022-07-01
|
| Edice: | Drugs in Context |
| Témata: | |
| On-line přístup: | https://www.drugsincontext.com/calcipotriol-betamethasone-foam-for-proactive-management-of-plaque-psoriasis-four-case-reports |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|